Adverse event profile of memantine and donepezil combination therapy: a real-world pharmacovigilance analysis based on FDA adverse event reporting system (FAERS) data from 2004 to 2023

• Hoofdauteurs: Yihan Yang (Auteur), Sheng Wei (Auteur), Huan Tian (Auteur), Jing Cheng (Auteur), Yue Zhong (Auteur), Xiaoling Zhong (Auteur), Dunbing Huang (Auteur), Cai Jiang (Auteur), Xiaohua Ke (Auteur)
• Formaat: Boek
• Gepubliceerd in: Frontiers Media S.A., 2024-07-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

BackgroundDonepezil in combination with memantine is a widely used clinical therapy for moderate to severe dementia. However, real-world population data on the long-term safety of donepezil in combination with memantine are incomplete and variable. Therefore, the aim of this study was to analyze the...